Spots Global Cancer Trial Database for advanced malignant neoplasm
Every month we try and update this database with for advanced malignant neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers | NCT01624766 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Anakinra Denosumab Everolimus | 18 Years - | M.D. Anderson Cancer Center | |
| A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | NCT04503265 | Advanced Malign... Breast Cancer Ovarian Cancer Homologous Reco... Prostate Cancer Pancreatic Canc... | AMXI-5001:Dose ... AMXI-5001:Dose ... | 18 Years - | AtlasMedx, Incorporated | |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer | NCT01582191 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Everolimus Laboratory Biom... Pharmacological... Vandetanib | - | M.D. Anderson Cancer Center | |
| Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations | NCT01531361 | Advanced Malign... BRAF Gene Mutat... Metastatic Mali... Recurrent Malig... Refractory Mali... | Crizotinib Laboratory Biom... Pharmacological... Sorafenib Tosyl... Vemurafenib | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets | NCT06165822 | Advanced Malign... | TQB3909 tablets Itraconazole ca... Rifampicin caps... | 18 Years - 45 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Financial Distress in Advanced Cancer Patients | NCT04053517 | Advanced Malign... Locally Advance... Metastatic Mali... Recurrent Malig... Refractory Mali... | Medical Chart R... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors | NCT06394713 | Advanced Malign... | QLF31907 Irinotecan Docetaxel | 18 Years - | Qilu Pharmaceutical Co., Ltd. | |
| RCT of QPS vs General Information Sheet | NCT03287492 | Advanced Malign... Caregiver Physician | Informational I... Informational I... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | NCT01867294 | Advanced Malign... Dermatologic Co... | Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd... | 18 Years - | Academic and Community Cancer Research United | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes | NCT02286687 | Advanced Malign... ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Metastatic Mali... PALB2 Gene Muta... Recurrent Malig... Refractory Mali... | Laboratory Biom... Pharmacological... Talazoparib | 18 Years - | M.D. Anderson Cancer Center | |
| Cordotomy in Reducing Pain in Patients With Advanced Cancer | NCT04119037 | Advanced Malign... | Cordotomy Morphine Questionnaire A... Sham Interventi... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer | NCT03203525 | Advanced Malign... Colorectal Carc... Metastatic Mali... Refractory Mali... | Bevacizumab Fluorouracil Leucovorin Oxaliplatin Pegylated Lipos... Temsirolimus Tumor Treating ... | 18 Years - | M.D. Anderson Cancer Center | |
| Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits | NCT03856060 | Advanced Malign... Locally Advance... Malignant Neopl... Metastatic Mali... Recurrent Malig... | Questionnaire A... Video | 18 Years - | M.D. Anderson Cancer Center | |
| Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer | NCT03049397 | Advanced Malign... | Communication I... Questionnaire A... | 5 Years - 65 Years | Fred Hutchinson Cancer Center | |
| Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer | NCT02823652 | Advanced Malign... Locally Advance... | standard geneti... Genetic Counsel... Genetic Testing Internet-Based ... Survey Administ... | 18 Years - | Eastern Cooperative Oncology Group | |
| Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study | NCT03707574 | Advanced Malign... Advanced Melano... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Lung... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVA Color... Stage IVA Lung ... Stage IVA Ovari... Stage IVA Prost... Stage IVB Color... Stage IVB Lung ... Stage IVB Ovari... Stage IVB Prost... Stage IVC Color... | Biospecimen Col... | 18 Years - | National Cancer Institute (NCI) | |
| Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | NCT01867294 | Advanced Malign... Dermatologic Co... | Doxycycline Management of T... Placebo Questionnaire A... Spironolactone Sunscreen Therapeutic Hyd... | 18 Years - | Academic and Community Cancer Research United | |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center | NCT03671226 | Advanced Malign... Caregiver Locally Advance... Metastatic Mali... | Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children | NCT02650583 | Advanced Malign... | Educational Int... Questionnaire A... | 25 Years - 65 Years | University of Washington | |
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia | NCT04067336 | Advanced Malign... Acute Myeloid L... Mixed Lineage L... Mixed Lineage A... Acute Leukemia ... Mixed Phenotype... | Ziftomenib | 18 Years - | Kura Oncology, Inc. | |
| Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer | NCT03592459 | Advanced Malign... Pain | Macy Catheter Pain Therapy Questionnaire A... Survey Administ... | 18 Years - | M.D. Anderson Cancer Center | |
| A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor | NCT05997342 | Advanced Malign... | TQB3912 tablets | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia | NCT04067336 | Advanced Malign... Acute Myeloid L... Mixed Lineage L... Mixed Lineage A... Acute Leukemia ... Mixed Phenotype... | Ziftomenib | 18 Years - | Kura Oncology, Inc. | |
| The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey | NCT01549067 | Advanced Malign... Colorectal Canc... | - | Chinese Medical Doctor Association | ||
| Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy | NCT03525873 | Advanced Malign... Metastatic Mali... Recurrent Malig... | Laboratory Biom... Methylphenidate Physical Activi... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes | NCT02286687 | Advanced Malign... ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Metastatic Mali... PALB2 Gene Muta... Recurrent Malig... Refractory Mali... | Laboratory Biom... Pharmacological... Talazoparib | 18 Years - | M.D. Anderson Cancer Center | |
| The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey | NCT01549067 | Advanced Malign... Colorectal Canc... | - | Chinese Medical Doctor Association | ||
| A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm | NCT05048160 | Advanced Malign... | Intravenous Inf... | 18 Years - | Mabwell (Shanghai) Bioscience Co., Ltd. | |
| Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin | NCT03122886 | Advanced Malign... | Fat Emulsion Placebo | 18 Years - | Mayo Clinic | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets | NCT06165822 | Advanced Malign... | TQB3909 tablets Itraconazole ca... Rifampicin caps... | 18 Years - 45 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center | NCT03671226 | Advanced Malign... Caregiver Locally Advance... Metastatic Mali... | Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies | NCT05861947 | Relapse Advanced Malign... Non Small Cell ... Gastric Cancer Urothelial Carc... Kidney Cancer Colon Cancer Esophagus Cance... | AUR106 | 18 Years - 99 Years | Aurigene Discovery Technologies Limited | |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer | NCT03203525 | Advanced Malign... Colorectal Carc... Metastatic Mali... Refractory Mali... | Bevacizumab Fluorouracil Leucovorin Oxaliplatin Pegylated Lipos... Temsirolimus Tumor Treating ... | 18 Years - | M.D. Anderson Cancer Center | |
| A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor | NCT05997342 | Advanced Malign... | TQB3912 tablets | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers | NCT03868423 | Advanced Malign... ALK Fusion Prot... ALK Gene Amplif... ALK Gene Mutati... Locally Advance... Metastatic Mali... Metastatic Mali... Metastatic Mali... ROS1 Fusion Pos... ROS1 Gene Ampli... ROS1 Gene Mutat... | Brigatinib Laboratory Biom... Quality-of-Life... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer | NCT00244972 | Advanced Malign... | Laboratory Biom... Sorafenib Tosyl... Tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer | NCT01582191 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Everolimus Laboratory Biom... Pharmacological... Vandetanib | - | M.D. Anderson Cancer Center | |
| RCT of QPS vs General Information Sheet | NCT03287492 | Advanced Malign... Caregiver Physician | Informational I... Informational I... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer | NCT06344351 | Advanced Malign... | TQB3006 tablets | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy | NCT05985278 | Advanced Malign... | [ Lu-177]-Catal... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors | NCT06394713 | Advanced Malign... | QLF31907 Irinotecan Docetaxel | 18 Years - | Qilu Pharmaceutical Co., Ltd. | |
| A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets | NCT06165822 | Advanced Malign... | TQB3909 tablets Itraconazole ca... Rifampicin caps... | 18 Years - 45 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer | NCT02491632 | Advanced Malign... Fatigue Metastatic Mali... Recurrent Malig... Refractory Mali... | Dexamethasone Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings | NCT04186884 | Advanced Malign... Locally Advance... Metastatic Mali... Recurrent Malig... | Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | NCT02646319 | Advanced Malign... Cervical Squamo... Endometrial Car... Malignant Uteri... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Head ... Recurrent Malig... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Solid Neoplasm Stage III Bladd... Stage III Prost... Stage III Renal... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIC Brea... Stage IIIC Ovar... Stage IV Breast... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IVA Bladd... Stage IVA Cervi... Stage IVB Bladd... Stage IVB Cervi... | Laboratory Biom... Nanoparticle Al... Quality-of-Life... | 18 Years - | Mayo Clinic | |
| TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors. | NCT06297642 | Advanced Malign... | TQB2928 injecti... Penpulimab | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer | NCT06165809 | Advanced Malign... | TQB3015 tablets | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
